Results 91 to 100 of about 4,872,021 (285)
Welcome to Volume 2 of ACS Organic & Inorganic Au. [PDF]
ACS Org Inorg Au, 2022 Masson G.
europepmc +1 more source
Molecular Oncology, EarlyView.A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel +12 more
wiley +1 more source
Molecular Oncology, EarlyView.This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
SL2 Limb Volume Measuring System Weitz (2)
, 1973 Graph of biomedical data for Skylab 2 Pilot Paul Weitz labeled SL2 Limb Volume Measuring System ...
core
“Wait-and-See” Strategy for Asymptomatic Patients with Common Bile Duct Stones
The Korean Journal of Gastroenterology, 2022 Yoon Suk Lee
doaj +1 more source
Editorial: Engineering the Plant Biofactory for the Production of Biologics and Small-Molecule Medicines-Volume 2. [PDF]
Front Plant Sci, 2022 De Martinis D +4 more
europepmc +1 more source
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
SL2 Limb Volume Measuring System Conrad (2)
, 1973 Graphs of biomedical data for Skylab 2 Commander Pete Conrad labeled SL2 Limb Volume Measuring System ...
core